Cognizant Technology Solutions Corp CTSH
We take great care to ensure that the data presented and summarized in this overview for COGNIZANT TECHNOLOGY SOLUTIONS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CTSH
View all-
Vanguard Group Inc Valley Forge, PA59MShares$4.87 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY53MShares$4.37 Billion0.08% of portfolio
-
State Street Corp Boston, MA24.9MShares$2.05 Billion0.08% of portfolio
-
Dodge & Cox San Francisco, CA18.3MShares$1.51 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY18.3MShares$1.51 Billion0.11% of portfolio
-
Richard Pzena Pzena Investment Management LLC17.7MShares$1.46 Billion4.78% of portfolio
-
Geode Capital Management, LLC Boston, MA13.4MShares$1.11 Billion0.08% of portfolio
-
Invesco Ltd. Atlanta, GA10.7MShares$879 Million0.16% of portfolio
-
First Trust Advisors LP Wheaton, IL8.43MShares$695 Million0.6% of portfolio
-
Morgan Stanley New York, NY7.29MShares$601 Million0.04% of portfolio
Latest Institutional Activity in CTSH
Top Purchases
Top Sells
About CTSH
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.
Insider Transactions at CTSH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 06
2025
|
Kathryn Diaz Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-2.25%
|
$26,208
$84.28 P/Share
|
Mar 06
2025
|
Kathryn Diaz Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+6.32%
|
-
|
Mar 04
2025
|
Jatin P Dalal Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,362
-13.23%
|
$196,046
$83.51 P/Share
|
Mar 04
2025
|
Jatin P Dalal Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,333
+19.53%
|
-
|
Mar 03
2025
|
John Sunshin Kim CLO, CAO & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
5,000
-12.44%
|
$415,000
$83.6 P/Share
|
Mar 01
2025
|
Jatin P Dalal Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,105
-7.56%
|
$91,715
$83.33 P/Share
|
Mar 01
2025
|
Jatin P Dalal Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+11.84%
|
-
|
Mar 01
2025
|
Surya Gummadi President - Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
930
-2.21%
|
$77,190
$83.33 P/Share
|
Mar 01
2025
|
Surya Gummadi President - Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
2,682
+1.59%
|
-
|
Mar 01
2025
|
Robert Telesmanic SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
404
-1.23%
|
$33,532
$83.33 P/Share
|
Mar 01
2025
|
Robert Telesmanic SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
933
+1.41%
|
-
|
Mar 01
2025
|
Kathryn Diaz Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-2.59%
|
$28,552
$83.33 P/Share
|
Mar 01
2025
|
Kathryn Diaz Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,036
+3.8%
|
-
|
Mar 01
2025
|
Ravi Kumar Singisetti Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,094
-3.2%
|
$173,802
$83.33 P/Share
|
Mar 01
2025
|
Ravi Kumar Singisetti Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,309
+7.51%
|
-
|
Mar 01
2025
|
Balu Ganesh Ayyar President - IOA & ISG |
BUY
Exercise of conversion of derivative security
|
Direct |
1,001
+0.57%
|
-
|
Mar 01
2025
|
John Sunshin Kim CLO, CAO & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-4.37%
|
$158,530
$83.33 P/Share
|
Mar 01
2025
|
John Sunshin Kim CLO, CAO & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,510
+2.67%
|
-
|
Feb 16
2025
|
Robert Telesmanic SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
251
-0.78%
|
$22,590
$90.7 P/Share
|
Feb 16
2025
|
Robert Telesmanic SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
576
+1.76%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 224K shares |
---|---|
Grant, award, or other acquisition | 2.67K shares |
Payment of exercise price or tax liability | 87K shares |
---|---|
Open market or private sale | 27.1K shares |